IGALMI Trademark

Trademark Overview

On Tuesday, November 3, 2020, a trademark application was filed for IGALMI with the United States Patent and Trademark Office. The USPTO has given the IGALMI trademark a serial number of 90295383. The federal status of this trademark filing is REGISTERED as of Tuesday, November 12, 2024. This trademark is owned by Bioxcel Therapeutics, Inc.. The IGALMI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of agitation, namely, an orally-dissolving formulation used for the treatment of agitation associated with central nervous system disorders, namely, schizophrenia and bipolar disorder
igalmi

General Information

Serial Number90295383
Word MarkIGALMI
Filing DateTuesday, November 3, 2020
Status700 - REGISTERED
Status DateTuesday, November 12, 2024
Registration Number7565627
Registration DateTuesday, November 12, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 18, 2021

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of agitation, namely, an orally-dissolving formulation used for the treatment of agitation associated with central nervous system disorders, namely, schizophrenia and bipolar disorder

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 31, 2020
Primary Code005
First Use Anywhere DateThursday, June 30, 2022
First Use In Commerce DateThursday, June 30, 2022

Trademark Owner History

Party NameBioxcel Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew Haven, CT 06516
Party NameBioxcel Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Haven, CT 06516
Party NameBioxcel Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Haven, CT 06516

Trademark Events

Event DateEvent Description
Thursday, December 31, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 6, 2020NEW APPLICATION ENTERED
Thursday, April 8, 2021ASSIGNED TO EXAMINER
Friday, April 9, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 28, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 18, 2021PUBLISHED FOR OPPOSITION
Tuesday, May 18, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 15, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, September 15, 2021OPPOSITION INSTITUTED NO. 999999
Monday, November 15, 2021OPPOSITION TERMINATED NO. 999999
Monday, November 15, 2021OPPOSITION DISMISSED NO. 999999
Monday, November 15, 2021TTAB RELEASE CASE TO TRADEMARKS
Tuesday, December 28, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 31, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, May 31, 2022SOU EXTENSION 1 FILED
Tuesday, May 31, 2022SOU EXTENSION 1 GRANTED
Thursday, June 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 6, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 6, 2022SOU EXTENSION 2 FILED
Tuesday, December 6, 2022SOU EXTENSION 2 GRANTED
Thursday, December 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 12, 2023SOU TEAS EXTENSION RECEIVED
Monday, June 12, 2023SOU EXTENSION 3 FILED
Monday, June 12, 2023SOU EXTENSION 3 GRANTED
Wednesday, June 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 19, 2023SOU EXTENSION 4 FILED
Tuesday, December 19, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 19, 2023SOU EXTENSION 4 GRANTED
Thursday, December 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 26, 2024SOU EXTENSION 5 FILED
Wednesday, June 26, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 21, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 22, 2024SOU EXTENSION 5 GRANTED
Thursday, August 22, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 8, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 8, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 12, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, November 12, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, June 26, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, June 26, 2024USE AMENDMENT FILED

Related Keywords

igalmi namely agitation treatment disorders system schizophrenia disorder nervous bipolar used